Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#81 / 88 Total
LESL - Leslies Inc - Stock Price Chart
TickerLESL [NASD]
CompanyLeslies Inc
CountryUSA
IndustrySpecialty Retail
Market Cap74.28MEPS (ttm)-0.24
P/E-EPS this Y169.67%
Forward P/E3.98EPS next Y1343.95%
PEG-EPS past 5Y-
P/S0.06EPS next 5Y-
P/B-EPS Q/Q-47.97%
Dividend-Sales Q/Q-6.11%
Insider Own3.39%Inst Own89.81%
Insider Trans4.27%Inst Trans-14.53%
Short Float6.01%EarningsMay 08/a
Analyst Recom2.92Target Price1.17
Avg Volume3.41M52W Range0.40 - 4.22
Leslie's, Inc. engages in the provision of direct-to-consumer pool and spa care services. It offers equipment installation and repair for residential consumers and professional pool operators. The company was founded in 1963 and is headquartered in Phoenix, AZ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Lindquist BenjaminSee RemarksMay 23 '25Option Exercise0.003,42408,647May 28 04:05 PM
LaBode MoyoSee RemarksMay 18 '25Option Exercise0.0011,596091,127May 20 04:05 PM
Cramer NaomiSee RemarksMay 18 '25Option Exercise0.0011,596039,773May 20 04:05 PM
Iskander Anthony ASee RemarksMay 13 '25Buy0.7863,99549,91665,995May 15 04:05 PM
Strain JohnDirectorMay 13 '25Buy0.79150,000118,500270,000May 14 04:05 PM
BBLG - Bone Biologics Corp - Stock Price Chart
TickerBBLG [NASD]
CompanyBone Biologics Corp
CountryUSA
IndustryMedical Devices
Market Cap4.65MEPS (ttm)-23.25
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y55.67%
P/S-EPS next 5Y79.61%
P/B0.54EPS Q/Q75.61%
Dividend-Sales Q/Q-
Insider Own0.04%Inst Own0.27%
Insider Trans0.00%Inst Trans0.14%
Short Float32.60%EarningsMay 28
Analyst Recom1.00Target Price22.50
Avg Volume512.93K52W Range2.87 - 25.50
Bone Biologics Corp. operates as a medical device company. engages in the research and development of bone regeneration in spinal fusion. Its product is Nell-1, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration. Its platform technology has application in delivering improved outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. The company was founded by Eric Kang Ting, Chia Soo and Benjamin Wu in 2004 and is headquartered in Burlington, MA.
IRT - Independence Realty Trust Inc - Stock Price Chart
TickerIRT [NYSE, RUT]
CompanyIndependence Realty Trust Inc
CountryUSA
IndustryREIT - Residential
Market Cap4.10BEPS (ttm)0.13
P/E129.35EPS this Y24.42%
Forward P/E60.69EPS next Y33.22%
PEG6.33EPS past 5Y-19.26%
P/S6.40EPS next 5Y20.43%
P/B1.16EPS Q/Q-53.85%
Dividend3.84%Sales Q/Q0.44%
Insider Own0.87%Inst Own100.85%
Insider Trans-0.57%Inst Trans1.17%
Short Float8.23%EarningsApr 30/a
Analyst Recom1.64Target Price21.68
Avg Volume2.21M52W Range17.10 - 22.10
Independence Realty Trust, Inc. is a real estate investment trust, which acquires, owns, operates, improves, and manages multifamily apartment communities across non-gateway U.S. markets. It operates through the Same-Store and Non Same-Store segments. The Same-Store segment includes properties that were owned and not a development property at the beginning of the previous year, and that have not been sold or identified as held for sale. The Non Same-Store segment refers to the properties that did not meet the definition of a same-store property as of the beginning of the previous year. The company was founded on March 26, 2009 and is headquartered in Philadelphia, PA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Gebert Richard DDirectorJul 01 '25Sale17.585008,79042,372Jul 02 05:30 PM
Gebert Richard DDirectorJun 02 '25Sale18.405009,20042,872Jun 02 05:30 PM
Gebert Richard DDirectorMay 01 '25Sale19.015009,50538,194May 02 05:00 PM
SCHAEFFER SCOTTChair Board and CEOApr 01 '25Sale21.2110,000212,100873,365Apr 02 05:34 PM
Gebert Richard DDirectorApr 01 '25Sale21.2850010,64038,694Apr 02 05:32 PM
FG - F&G Annuities & Life Inc - Stock Price Chart
TickerFG [NYSE, RUT]
CompanyF&G Annuities & Life Inc
CountryUSA
IndustryInsurance - Life
Market Cap4.04BEPS (ttm)3.70
P/E8.12EPS this Y-21.21%
Forward P/E5.46EPS next Y62.24%
PEG0.57EPS past 5Y-
P/S0.79EPS next 5Y14.23%
P/B0.93EPS Q/Q-123.24%
Dividend2.90%Sales Q/Q-40.73%
Insider Own2.19%Inst Own96.18%
Insider Trans155.56%Inst Trans29.68%
Short Float0.44%EarningsMay 07/a
Analyst Recom3.00Target Price34.67
Avg Volume220.63K52W Range30.10 - 50.75
F&G Annuities & Life, Inc. engages in the provision of fixed annuity and life insurance products. It specializes in life insurance, annuities, retirement planning and wealth transfer. The company was founded in 1959 and is headquartered in Des Moines, IA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Blunt Christopher OChief Executive OfficerMay 19 '25Buy31.886,000191,280900,964May 19 04:03 PM
Blunt Christopher OChief Executive OfficerMay 16 '25Buy32.115,000160,550894,964May 16 05:35 PM
Blunt Christopher OChief Executive OfficerMay 15 '25Buy30.7815,000461,700889,964May 15 04:27 PM
Blunt Christopher OChief Executive OfficerMay 12 '25Buy31.3115,000469,650874,964May 12 04:38 PM
Blunt Christopher OChief Executive OfficerMay 09 '25Buy30.8010,000307,953859,860May 09 07:44 PM
HSON - Hudson Global Inc - Stock Price Chart
TickerHSON [NASD]
CompanyHudson Global Inc
CountryUSA
IndustryStaffing & Employment Services
Market Cap23.30MEPS (ttm)-1.22
P/E-EPS this Y125.58%
Forward P/E3.85EPS next Y900.00%
PEG-EPS past 5Y-42.68%
P/S0.17EPS next 5Y-
P/B0.59EPS Q/Q38.27%
Dividend-Sales Q/Q-5.98%
Insider Own19.01%Inst Own52.36%
Insider Trans0.00%Inst Trans-1.88%
Short Float0.09%EarningsMay 13/b
Analyst Recom1.00Target Price19.00
Avg Volume9.41K52W Range8.28 - 18.99
Hudson Global, Inc. is a talent solutions company, which engages in the provision of recruitment outsourcing and total talent solutions to organizations. It operates through the following segments: Americas, Asia Pacific, Europe, Middle East and Africa. The firm's services include complete recruitment outsourcing, project-based outsourcing, contingent workforce solutions, and recruitment consulting. The company was founded in 2003 and is headquartered in Old Greenwich, CT.
EXPO - Exponent Inc - Stock Price Chart
TickerEXPO [NASD, RUT]
CompanyExponent Inc
CountryUSA
IndustryEngineering & Construction
Market Cap3.67BEPS (ttm)2.04
P/E35.38EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y6.67%
P/S6.57EPS next 5Y-
P/B8.33EPS Q/Q-11.98%
Dividend1.60%Sales Q/Q0.40%
Insider Own1.07%Inst Own94.36%
Insider Trans-1.45%Inst Trans0.62%
Short Float3.90%EarningsJul 31/a
Analyst Recom2.25Target Price92.00
Avg Volume318.44K52W Range72.43 - 115.75
Exponent, Inc. is an engineering and scientific consulting company, which provides engineering, scientific, environmental, and health consulting services. It operates through the Engineering and Other Scientific, and Environmental and Health segments. The Engineering and Other Scientific segment includes technical consulting in different practices primarily in engineering. The Environmental and Health segment offers services in environmental, epidemiology, and health risk analysis. The company was founded by Bernard Ross in 1967 and is headquartered in Menlo Park, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Rakow JosephGroup Vice PresidentMay 27 '25Sale77.721,573122,2540May 27 08:27 PM
JOSEPH RAKOWOfficerMay 27 '25Proposed Sale77.721,573122,254May 27 04:07 PM
JOHN PYEOfficerMay 23 '25Proposed Sale76.322,000152,639May 23 06:02 PM
Pye JohnGroup Vice PresidentMay 23 '25Sale76.322,000152,63929,204May 23 04:59 PM
James Bradley AGroup Vice PresidentMay 20 '25Sale79.522,694214,2330May 21 05:04 PM
TNFA - TNF Pharmaceuticals Inc - Stock Price Chart
TickerTNFA [NASD]
CompanyTNF Pharmaceuticals Inc
CountryUSA
IndustryBiotechnology
Market Cap1.51MEPS (ttm)-6.95
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y50.65%
P/S-EPS next 5Y-
P/B0.09EPS Q/Q92.95%
Dividend-Sales Q/Q-
Insider Own4.98%Inst Own1.44%
Insider Trans0.00%Inst Trans-51.69%
Short Float29.03%Earnings-
Analyst Recom1.00Target Price32.00
Avg Volume5.19M52W Range0.10 - 2.16
Jun-24-25 09:15AM TNF Pharmaceuticals Collaborates with DADA2 Foundation for Compassionate Use Study of Isomyosamine in Rare Pediatric Autoinflammatory Disease (Business Wire)
May-08-25 09:20AM TNF Pharmaceuticals and Renova Health Report Positive Results in Identifying Targets for Treating TNF-Driven Inflammation in Patients Receiving GLP-1 Agonists (Business Wire)
Apr-22-25 09:15AM TNF Pharmaceuticals and Renova Health Utilize AI to Accelerate Drug Development (Business Wire)
Apr-16-25 09:15AM TNF Pharmaceuticals Delivers Platform Presentation of Oral TNF-Alpha Inhibitor Isomyosamine at British Geriatrics Society's Spring Meeting 2025 (Business Wire) -9.00%
Mar-18-25 09:25AM TNF Pharmaceuticals presents isomyosamine data (TipRanks)
Mar-17-25 09:15AM TNF Pharmaceuticals Delivers Podium Presentation of Novel Oral TNF-Alpha Inhibitor at Premier International Conference on Frailty and Sarcopenia (Business Wire) +5.49%
Mar-05-25 09:00AM TNF Pharmaceuticals to Host Investor Conference Call and Webcast Featuring Clinical Scientific Updates on Thursday, March 6, 2025 (Business Wire)
Feb-25-25 09:20AM TNF Pharmaceuticals Initiates Phase 2b Clinical Trial of First Oral TNF-Alpha Inhibitor (Business Wire) +5.55%
Jan-29-25 09:15AM TNF Pharmaceuticals Launches Study Series Aimed at Preserving Lean Muscle Mass During GLP-1 Weight Loss Treatment (Business Wire) -9.83%
Jan-15-25 09:15AM TNF Pharmaceuticals Announces Positive Clinical Data Supporting Clinical Trial Expansion (Business Wire) -20.27%
TNF Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical company, which engages in the development of drug products to extend healthy lifespan. It focuses on developing two novel therapeutic platforms, MyMD-1 and SUPERA-CBD, which aim to treat the causes of disease rather than just addressing the symptoms. MyMD-1 is a clinical-stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and other pro-inflammatory cytokines. SUPERA-CBD is a synthetic derivative of cannabidiol being developed to treat conditions such as epilepsy, chronic pain, depression, as well as neuroinflammatory and neurodegenerative diseases. The company was founded in 1989 and is headquartered in New York, NY.
CENN - Cenntro Inc - Stock Price Chart
TickerCENN [NASD]
CompanyCenntro Inc
CountryUSA
IndustryAuto Manufacturers
Market Cap29.47MEPS (ttm)-1.34
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y42.34%
P/S0.98EPS next 5Y-
P/B0.26EPS Q/Q38.81%
Dividend-Sales Q/Q-36.82%
Insider Own28.28%Inst Own1.26%
Insider Trans0.00%Inst Trans-15.61%
Short Float0.96%EarningsApr 02/b
Analyst Recom-Target Price-
Avg Volume255.38K52W Range0.61 - 1.83
Cenntro, Inc. is a commercial electric vehicle technology company, which engages in the sale and production of electric vehicles. It provides support to city services, last-mile delivery, and other commercial applications. The company was founded on March 9, 2023 and is headquartered in Freehold, NJ.
123456789